• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2022 Aug;28(8):1669-1672.
doi: 10.3201/eid2808.220304.
Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England

Marta Bertran, Zahin Amin-Chowdhury, Carmen L Sheppard, Seyi Eletu, Dania V Zamarreño, Mary E Ramsay, David Litt, Norman K Fry, Shamez N Ladhani

Abstract

During July-December 2021, after COVID-19 restrictions were removed in England, invasive pneumococcal disease incidence in children <15 years of age was higher (1.96/100,000 children) than during the same period in 2020 (0.7/100,000 children) and in prepandemic years 2017-2019 (1.43/100,000 children). Childhood vaccine coverage should be maintained to protect the population.

Keywords: COVID-19; England; SARS-CoV-2; United Kingdom; bacteria; coronavirus disease; epidemiologic surveillance; incidence; invasive pneumococcal disease; pneumococcal diseases; pneumococcal vaccines; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccine-preventable diseases; viruses.
 
Back
Top Bottom